EFFECTS OF A LONG-ACTING GONADOTROPIN-RELEASING-HORMONE AGONIST (LEUPROLIDE) ON OVARIAN FOLLICULAR DEVELOPMENT IN PREPUBERTAL HEIFER CALVES

被引:11
|
作者
EVANS, ACO [1 ]
RAWLINGS, NC [1 ]
机构
[1] UNIV SASKATCHEWAN, WESTERN COLL VET MED, DEPT VET PHYSIOL SCI, SASKATOON, SK S7N 0W0, CANADA
关键词
FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HEIFER CALVES; LUTEINIZING HORMONE OVARIAN FOLLICLES;
D O I
10.4141/cjas94-094
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
We studied the effects of reducing gonadotrophin secretion on ovarian follicular development in young prepubertal heifer calves. Calves received a GnRH agonist (n = 5, 15 mg of Leuprolide acetate, i.m.) or carrier (n = 5) at 8 and 12 w of age. Starting at 8 and 34 w of age, ovarian follicles were monitored daily for 17 d, and at 10, 15, 25 and 35 w of age, blood samples were collected every 15 min for 12 h for measurement of serum concentration of LH and FSH. GnRH agonist treatment did not affect the age and body weight at puberty (P>0.05). Agonist treatment suppressed follicle numbers and in two heifers follicle emergence (growth above 4-5 mm) was blocked immediately. In three agonist-treated heifers, follicle emergence was blocked after one extended wave of follicular growth. At 34 w of age the pattern of ovarian follicular growth did not differ between groups but oestradiol secretion was lower in agonist-treated heifers. During agonist treatment basal and mean concentrations of FSH, and LH and FSH pulse amplitude were decreased but basal LH concentrations increased (P<0.05). At 25 and 35 w of age some rebound in gonadotrophin secretion was seen. We concluded that disrupting gonadotrophin secretion in young prepubertal heifer calves by GnRH agonist treatment, suppressed ovarian follicular growth but that a rebound in gonadotrophin secretion prevented long term-effects on sexual development.
引用
收藏
页码:649 / 656
页数:8
相关论文
共 50 条
  • [1] THE COMPARISON OF EARLY FOLLICULAR AND MIDLUTEAL ADMINISTRATION OF LONG-ACTING GONADOTROPIN-RELEASING-HORMONE AGONIST
    RONEL, R
    HERMAN, A
    GOLAN, A
    VANDERVEN, H
    CASPI, E
    DIEDRICH, K
    FERTILITY AND STERILITY, 1990, 54 (02) : 233 - 237
  • [2] TREATMENT OF ENDOMETRIOSIS WITH A LONG-ACTING GONADOTROPIN-RELEASING-HORMONE AGONIST
    STEINGOLD, KA
    CEDARS, M
    LU, JKH
    RANDLE, D
    JUDD, HL
    MELDRUM, DR
    OBSTETRICS AND GYNECOLOGY, 1987, 69 (03): : 403 - 411
  • [3] COMPARATIVE EFFECTS OF CYPROTERONE-ACETATE OR A LONG-ACTING GONADOTROPIN-RELEASING-HORMONE AGONIST IN POLYCYSTIC OVARIAN DISEASE
    COUZINET, B
    LESTRAT, N
    BRAILLY, S
    SCHAISON, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04): : 1031 - 1035
  • [4] CATAMENIAL INSULIN REACTIONS TREATED WITH A LONG-ACTING GONADOTROPIN-RELEASING-HORMONE AGONIST
    LETTERIE, GS
    FREDLUND, PN
    ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (16) : 1868 - 1870
  • [5] TREATMENT OF SEVERE ANDROGEN EXCESS DUE TO OVARIAN HYPERTHECOSIS WITH A LONG-ACTING GONADOTROPIN-RELEASING-HORMONE AGONIST
    STEINGOLD, KA
    JUDD, HL
    NIEBERG, RK
    LU, JKH
    CHANG, RJ
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 154 (06) : 1241 - 1248
  • [6] USE OF A POTENT, LONG-ACTING AGONIST OF GONADOTROPIN-RELEASING-HORMONE IN THE TREATMENT OF PRECOCIOUS PUBERTY
    BOEPPLE, PA
    MANSFIELD, MJ
    WIERMAN, ME
    RUDLIN, CR
    BODE, HH
    CRIGLER, JF
    CRAWFORD, JD
    CROWLEY, WF
    ENDOCRINE REVIEWS, 1986, 7 (01) : 24 - 33
  • [7] DEVELOPMENT OF CHILDREN BORN AFTER OVARIAN SUPEROVULATION INDUCED BY LONG-ACTING GONADOTROPIN-RELEASING-HORMONE AGONIST AND MENOTROPINS, AND BY IN-VITRO FERTILIZATION
    RONEL, R
    LAHAT, E
    GOLAN, A
    LERMAN, M
    BUKOVSKY, I
    HERMAN, A
    JOURNAL OF PEDIATRICS, 1994, 125 (05): : 734 - 737
  • [8] EFFECTS OF AN AGONIST OF GONADOTROPIN-RELEASING-HORMONE ON OVARIAN FOLLICLES IN CATTLE
    MACMILLAN, KL
    THATCHER, WW
    BIOLOGY OF REPRODUCTION, 1991, 45 (06) : 883 - 889
  • [9] LONG-ACTING GONADOTROPIN-RELEASING-HORMONE AGONIST IMPLANT CAUSES VARIABLE DURATION OF SUPPRESSION OF OVARIAN-STEROID AND INHIBIN SECRETION
    FRASER, HM
    HAINING, R
    COWEN, GM
    SANDOW, J
    SMITH, KB
    SMITH, SK
    CLINICAL ENDOCRINOLOGY, 1992, 36 (01) : 97 - 104
  • [10] OVARIAN HYPERSTIMULATION SYNDROME-ASSOCIATED WITH THE USE OF THE GONADOTROPIN-RELEASING-HORMONE AGONIST LEUPROLIDE ACETATE
    DROESCH, K
    BARBIERI, RL
    FERTILITY AND STERILITY, 1994, 62 (01) : 189 - 190